Lake Street Maintains Buy on Inspire Medical Systems, Raises Price Target to $350
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Frank Takkinen maintains a 'Buy' rating on Inspire Medical Systems (NYSE:INSP) and raises the price target from $305 to $350.
August 04, 2023 | 11:45 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inspire Medical Systems' price target has been raised from $305 to $350 by Lake Street analyst Frank Takkinen, who maintains a 'Buy' rating on the stock.
The raised price target and maintained 'Buy' rating by Lake Street analyst indicates a positive outlook for Inspire Medical Systems. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100